Los Angeles Capital Management & Equity Research Inc. Boosts Stake in Amsurg Corp. (AMSG)
Los Angeles Capital Management & Equity Research Inc. increased its position in Amsurg Corp. (NASDAQ:AMSG) by 47.9% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 8,335 shares of the company’s stock after buying an additional 2,700 shares during the period. Los Angeles Capital Management & Equity Research Inc.’s holdings in Amsurg Corp. were worth $646,000 at the end of the most recent quarter.
Several other hedge funds also recently made changes to their positions in the company. Stephens Inc. AR raised its position in shares of Amsurg Corp. by 21.4% in the second quarter. Stephens Inc. AR now owns 15,305 shares of the company’s stock worth $1,187,000 after buying an additional 2,699 shares during the last quarter. Janney Montgomery Scott LLC raised its stake in Amsurg Corp. by 57.2% in the second quarter. Janney Montgomery Scott LLC now owns 5,219 shares of the company’s stock worth $397,000 after buying an additional 1,898 shares during the last quarter. Boston Partners raised its stake in Amsurg Corp. by 1.0% in the second quarter. Boston Partners now owns 386,794 shares of the company’s stock worth $29,992,000 after buying an additional 3,792 shares during the last quarter. Sivik Global Healthcare LLC raised its stake in Amsurg Corp. by 14.3% in the second quarter. Sivik Global Healthcare LLC now owns 40,000 shares of the company’s stock worth $3,102,000 after buying an additional 5,000 shares during the last quarter. Finally, GSA Capital Partners LLP raised its stake in Amsurg Corp. by 266.8% in the second quarter. GSA Capital Partners LLP now owns 10,137 shares of the company’s stock worth $786,000 after buying an additional 7,373 shares during the last quarter. Institutional investors and hedge funds own 98.42% of the company’s stock.
Shares of Amsurg Corp. (NASDAQ:AMSG) traded up 1.53% on Wednesday, reaching $63.81. 947,746 shares of the company’s stock were exchanged. The firm’s 50-day moving average price is $66.32 and its 200 day moving average price is $73.88. Amsurg Corp. has a 12 month low of $58.37 and a 12 month high of $87.42. The company has a market cap of $3.43 billion, a price-to-earnings ratio of 18.93 and a beta of 0.65.
Amsurg Corp. (NASDAQ:AMSG) last issued its quarterly earnings results on Tuesday, August 2nd. The company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.08 by $0.02. Amsurg Corp. had a net margin of 6.53% and a return on equity of 8.20%. The firm had revenue of $758.50 million for the quarter, compared to analysts’ expectations of $769.88 million. During the same period in the previous year, the firm posted $0.97 EPS. The company’s revenue for the quarter was up 21.5% on a year-over-year basis. Equities research analysts predict that Amsurg Corp. will post $4.33 EPS for the current fiscal year.
Several analysts recently issued reports on the company. Bank of America Corp. upgraded Amsurg Corp. from a “neutral” rating to a “buy” rating and set a $104.00 price objective for the company in a report on Thursday, June 16th. Jefferies Group reissued a “buy” rating on shares of Amsurg Corp. in a research report on Sunday, July 3rd. Citigroup Inc. downgraded shares of Amsurg Corp. from a “buy” rating to a “neutral” rating in a research report on Thursday, June 16th. Wells Fargo & Co. started coverage on Amsurg Corp. in a research report on Tuesday, June 14th. They issued a “market perform” rating on the stock. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $95.00 price target on shares of Amsurg Corp. in a research report on Thursday, July 14th. Four research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $93.90.
In other Amsurg Corp. news, insider Robert Jon Coward sold 7,500 shares of the business’s stock in a transaction dated Friday, August 26th. The shares were sold at an average price of $63.65, for a total transaction of $477,375.00. Following the sale, the insider now directly owns 97,507 shares of the company’s stock, valued at approximately $6,206,320.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 2.30% of the company’s stock.
Amsurg Corp. Company Profile
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Want to see what other hedge funds are holding AMSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amsurg Corp. (NASDAQ:AMSG).
Receive News & Ratings for Amsurg Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amsurg Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.